🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Andreas Halvorsen’s MDLN Holdings & Trades

First Buy
Q4 2025
Duration Held
2 Quarters
Largest Add
Q4 2025
+6.96 M Shares
Current Position
11.43 M Shares
$508.81 M Value

Andreas Halvorsen's MDLN Position Overview

Andreas Halvorsen (via Viking Global Investors Lp) currently holds 11.43 M shares of Medline Inc. (MDLN) worth $508.81 M, representing 1.42% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 2 quarters.

Based on recent 13F filings, Andreas Halvorsen has initiated a new position in MDLN, representing a fresh investment thesis on this company. Largest addition occurred in Q1 2026, adding 4.47 M shares.

Analysis based on 13F filings available since 2013 Q2

Andreas Halvorsen's Medline (MDLN) Holding Value Over Time

Track share changes against reported price movement

Quarterly Medline (MDLN) Trades by Andreas Halvorsen

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q1 2026 +4.47 M Add 64.30% 11.43 M $44.50
Q4 2025 +6.96 M New Buy 6.96 M $42.00

Andreas Halvorsen's Medline Investment FAQs

Andreas Halvorsen first purchased Medline Inc. (MDLN) in Q4 2025, acquiring 6,959,157 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Andreas Halvorsen has held Medline Inc. (MDLN) for 2 quarters since Q4 2025.

Andreas Halvorsen's largest addition to Medline Inc. (MDLN) was in Q4 2025, adding 6,959,157 shares worth $292.28 M.

According to the latest 13F filing for Q1 2026, Andreas Halvorsen's firm, Viking Global Investors Lp, owns 11,433,992 shares of Medline Inc. (MDLN), valued at approximately $508.81 M.

As of the Q1 2026 filing, Medline Inc. (MDLN) represents approximately 1.42% of Andreas Halvorsen's publicly disclosed stock portfolio, making it one of their key holdings.

Andreas Halvorsen's peak holding in Medline Inc. (MDLN) was 11,433,992 shares, as reported at the end of Q1 2026.